» Articles » PMID: 16286459

Zinc and Calcium Ions Cooperatively Modulate ADAMTS13 Activity

Overview
Journal J Biol Chem
Specialty Biochemistry
Date 2005 Nov 16
PMID 16286459
Citations 36
Authors
Affiliations
Soon will be listed here.
Abstract

ADAMTS13 is a metalloproteinase that cleaves von Willebrand factor (VWF) multimers. The metal ion dependence of ADAMTS13 activity was examined with multimeric VWF and a fluorescent peptide substrate based on Asp(1596)-Arg(1668) of the VWF A2 domain, FRETS-VWF73. ADAMTS13 activity in citrate-anticoagulated plasma was enhanced approximately 2-fold by zinc ions, approximately 3-fold by calcium ions, and approximately 6-fold by both ions, suggesting cooperative activation. Cleavage of VWF by recombinant ADAMTS13 was activated up to approximately 200-fold by zinc ions (K(D) (app) approximately 0.5 microM), calcium ions (K(D) (app) approximately 4.8 microM), and barium ions (K(D) (app) approximately 1.7 mM). Barium ions stimulated ADAMTS13 activity in citrated plasma but not in citrate-free plasma. Therefore, the stimulation by barium ions of ADAMTS13 in citrated plasma appears to reflect the release of chelated calcium and zinc ions from complexes with citrate. At optimal zinc and calcium concentrations, ADAMTS13 cleaved VWF with a K(m) (app) of 3.7 +/- 1.4 microg/ml (approximately 15 nM for VWF subunits), which is comparable with the plasma VWF concentration of 5-10 microg/ml. ADAMTS13 could cleave approximately 14% of VWF pretreated with guanidine HCl, suggesting that this substrate is heterogeneous in susceptibility to proteolysis. ADAMTS13 cleaved FRETS-VWF73 with a K(m) (app) of 3.2 +/- 1.1 microM, consistent with an approximately 200-fold decrease in affinity compared with VWF. ADAMTS13 cleaved VWF and FRETS-VWF73 with roughly comparable catalytic efficiency of 55 microM(-1) min(-1) and 18 microM(-1) min(-1), respectively. The striking preference of ADAMTS13 for VWF suggests that substrate recognition depends on structural features or exosites on multimeric VWF that are missing from FRETS-VWF73.

Citing Articles

A Long-Term Follow-Up Study in Immune-Mediated Thrombotic Thrombocytopenic Purpura: What Are the Outcomes?.

Bonifacio M, Roselli D, Schifone C, Ricco A, Vitucci A, Aprile L J Clin Med. 2023; 12(23).

PMID: 38068357 PMC: 10707723. DOI: 10.3390/jcm12237305.


A novel mechanism underlying allosteric regulation of ADAMTS-13 revealed by hydrogen-deuterium exchange plus mass spectrometry.

Pillai V, Zheng X Res Pract Thromb Haemost. 2023; 7(1):100012.

PMID: 36852110 PMC: 9958085. DOI: 10.1016/j.rpth.2022.100012.


Synonymous ADAMTS13 variants impact molecular characteristics and contribute to variability in active protein abundance.

Jankowska K, Meyer D, Holcomb D, Kames J, Hamasaki-Katagiri N, Katneni U Blood Adv. 2022; 6(18):5364-5378.

PMID: 35667091 PMC: 9631689. DOI: 10.1182/bloodadvances.2022007065.


Pathologic Shear and Elongation Rates Do Not Cause Cleavage of Von Willebrand Factor by ADAMTS13 in a Purified System.

Bortot M, Sharifi A, Ashworth K, Walker F, Cox A, Ruegg K Cell Mol Bioeng. 2020; 13(4):379-390.

PMID: 32952737 PMC: 7479076. DOI: 10.1007/s12195-020-00631-2.


Microthrombotic Complications of COVID-19 Are Likely Due to Embolism of Circulating Endothelial Derived Ultralarge von Willebrand Factor (eULVWF) Decorated-Platelet Strings.

Varatharajah N, Rajah S Fed Pract. 2020; 37(6):258-259.

PMID: 32669777 PMC: 7357889.